Limits...
Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment.

Voisard R, Kucharczyk E, Deininger U, Baur R, Hombach V - BMC Cardiovasc Disord (2002)

Bottom Line: At day 7 and 28 proliferative activity (BrdU), neointimal thickening, and staining against smooth muscle alpha-actin and vWF was analysed. 7 days after ballooning administration of diltiazem for 4, 5, 6, and 7 days inhibited reactive cell proliferation by more than 50% (n.s.) as compared to control, 28 days after ballooning administration for 6 and 7 days inhibited neointimal thickening by more than 75% (p < 0.05).Simultaneous intra/extravascular administration of high dose diltiazem did not affect the expression of vWF in endothelial cells or smooth muscle alpha-actin in smooth muscle cells.Simultaneous intra/extravascular administration of high dose diltiazem (50 microg/mL) has to be maintained for at least 6 days to achieve a significant inhibition of neointimal thickening.

View Article: PubMed Central - HTML - PubMed

Affiliation: Department of Internal Medicine II-Cardiology, University of Ulm, Germany. rainer.voisard@medizin.uni-ulm.de

ABSTRACT

Background: Strictly intravascular approaches for the treatment of postangioplasty restenosis are effective in the intima and the inner parts of the media but may be insufficient to control redundant pathways in the more outer parts of the media and the adventitia. An inverse situation may occur subsequently to a strictly extravascular approach, like the recently suggested pericardial approach in pigs. We hypothesized that simultaneous intra/extravascular administration of anti-restenotic agents inhibits restenosis by blocking all stimulatory pathways in the entire arterial wall.

Methods: Fresh hearts of 25 domestic pigs were obtained from a local slaughterhouse. Left anterior descending coronary arteries (LAD) were harvested, cut into cylindric 5 mm segments, and cultured as ex vivo porcine organ cultures (POCs). After 9 bar ballooning simultaneous intra/extravascular administration of high dose diltiazem (50 microg/mL) was carried out for a period of 1, 2, 3, 4, 5, 6, and 7 days. At day 7 and 28 proliferative activity (BrdU), neointimal thickening, and staining against smooth muscle alpha-actin and vWF was analysed.

Results: 7 days after ballooning administration of diltiazem for 4, 5, 6, and 7 days inhibited reactive cell proliferation by more than 50% (n.s.) as compared to control, 28 days after ballooning administration for 6 and 7 days inhibited neointimal thickening by more than 75% (p < 0.05). Simultaneous intra/extravascular administration of high dose diltiazem did not affect the expression of vWF in endothelial cells or smooth muscle alpha-actin in smooth muscle cells.

Conclusions: Simultaneous intra/extravascular administration of high dose diltiazem (50 microg/mL) has to be maintained for at least 6 days to achieve a significant inhibition of neointimal thickening. The data demonstrate the importance of the maximal reactive cell proliferation (= day 7 in the POC-model) for the calculation of the duration of the treatment period.

Show MeSH

Related in: MedlinePlus

Micrographs of sections of porcine coronoary organ cultures at day 28, staining with elastica van gieson: untreated control (A), ex vivo ballooning (B) and ex vivo ballooning with simultaneous intra/extravascular antiproliferative drug therapy (C). arrow = area of neointimal thickening.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC65511&req=5

Figure 4: Micrographs of sections of porcine coronoary organ cultures at day 28, staining with elastica van gieson: untreated control (A), ex vivo ballooning (B) and ex vivo ballooning with simultaneous intra/extravascular antiproliferative drug therapy (C). arrow = area of neointimal thickening.

Mentions: The effect of simultaneous intra/extravascular administration of high dose diltiazem on relative neointimal thickening was analysed 7 and 28 days after 9 bar ballooning (Fig. 3 and 4).


Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment.

Voisard R, Kucharczyk E, Deininger U, Baur R, Hombach V - BMC Cardiovasc Disord (2002)

Micrographs of sections of porcine coronoary organ cultures at day 28, staining with elastica van gieson: untreated control (A), ex vivo ballooning (B) and ex vivo ballooning with simultaneous intra/extravascular antiproliferative drug therapy (C). arrow = area of neointimal thickening.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC65511&req=5

Figure 4: Micrographs of sections of porcine coronoary organ cultures at day 28, staining with elastica van gieson: untreated control (A), ex vivo ballooning (B) and ex vivo ballooning with simultaneous intra/extravascular antiproliferative drug therapy (C). arrow = area of neointimal thickening.
Mentions: The effect of simultaneous intra/extravascular administration of high dose diltiazem on relative neointimal thickening was analysed 7 and 28 days after 9 bar ballooning (Fig. 3 and 4).

Bottom Line: At day 7 and 28 proliferative activity (BrdU), neointimal thickening, and staining against smooth muscle alpha-actin and vWF was analysed. 7 days after ballooning administration of diltiazem for 4, 5, 6, and 7 days inhibited reactive cell proliferation by more than 50% (n.s.) as compared to control, 28 days after ballooning administration for 6 and 7 days inhibited neointimal thickening by more than 75% (p < 0.05).Simultaneous intra/extravascular administration of high dose diltiazem did not affect the expression of vWF in endothelial cells or smooth muscle alpha-actin in smooth muscle cells.Simultaneous intra/extravascular administration of high dose diltiazem (50 microg/mL) has to be maintained for at least 6 days to achieve a significant inhibition of neointimal thickening.

View Article: PubMed Central - HTML - PubMed

Affiliation: Department of Internal Medicine II-Cardiology, University of Ulm, Germany. rainer.voisard@medizin.uni-ulm.de

ABSTRACT

Background: Strictly intravascular approaches for the treatment of postangioplasty restenosis are effective in the intima and the inner parts of the media but may be insufficient to control redundant pathways in the more outer parts of the media and the adventitia. An inverse situation may occur subsequently to a strictly extravascular approach, like the recently suggested pericardial approach in pigs. We hypothesized that simultaneous intra/extravascular administration of anti-restenotic agents inhibits restenosis by blocking all stimulatory pathways in the entire arterial wall.

Methods: Fresh hearts of 25 domestic pigs were obtained from a local slaughterhouse. Left anterior descending coronary arteries (LAD) were harvested, cut into cylindric 5 mm segments, and cultured as ex vivo porcine organ cultures (POCs). After 9 bar ballooning simultaneous intra/extravascular administration of high dose diltiazem (50 microg/mL) was carried out for a period of 1, 2, 3, 4, 5, 6, and 7 days. At day 7 and 28 proliferative activity (BrdU), neointimal thickening, and staining against smooth muscle alpha-actin and vWF was analysed.

Results: 7 days after ballooning administration of diltiazem for 4, 5, 6, and 7 days inhibited reactive cell proliferation by more than 50% (n.s.) as compared to control, 28 days after ballooning administration for 6 and 7 days inhibited neointimal thickening by more than 75% (p < 0.05). Simultaneous intra/extravascular administration of high dose diltiazem did not affect the expression of vWF in endothelial cells or smooth muscle alpha-actin in smooth muscle cells.

Conclusions: Simultaneous intra/extravascular administration of high dose diltiazem (50 microg/mL) has to be maintained for at least 6 days to achieve a significant inhibition of neointimal thickening. The data demonstrate the importance of the maximal reactive cell proliferation (= day 7 in the POC-model) for the calculation of the duration of the treatment period.

Show MeSH
Related in: MedlinePlus